326 related articles for article (PubMed ID: 15316512)
1. Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions.
Tapia B; Padial A; Sánchez-Sabaté E; Alvarez-Ferreira J; Morel E; Blanca M; Bellón T
J Allergy Clin Immunol; 2004 Aug; 114(2):335-40. PubMed ID: 15316512
[TBL] [Abstract][Full Text] [Related]
2. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides.
Fujita Y; Abe R; Sasaki M; Honda A; Furuichi M; Asano Y; Norisugi O; Shimizu T; Shimizu H
Clin Cancer Res; 2006 May; 12(9):2670-5. PubMed ID: 16675558
[TBL] [Abstract][Full Text] [Related]
3. A possible role for CCL27/CTACK-CCR10 interaction in recruiting CD4 T cells to skin in human graft-versus-host disease.
Faaij CM; Lankester AC; Spierings E; Hoogeboom M; Bowman EP; Bierings M; Révész T; Egeler RM; van Tol MJ; Annels NE
Br J Haematol; 2006 Jun; 133(5):538-49. PubMed ID: 16681643
[TBL] [Abstract][Full Text] [Related]
4. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
5. Increased CCL27-CCR10 expression in allergic contact dermatitis: implications for local skin memory.
Moed H; Boorsma DM; Tensen CP; Flier J; Jonker MJ; Stoof TJ; von Blomberg BM; Bruynzeel DP; Scheper RJ; Rustemeyer T; Gibbs S
J Pathol; 2004 Sep; 204(1):39-46. PubMed ID: 15307136
[TBL] [Abstract][Full Text] [Related]
6. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation.
Homey B; Alenius H; Müller A; Soto H; Bowman EP; Yuan W; McEvoy L; Lauerma AI; Assmann T; Bünemann E; Lehto M; Wolff H; Yen D; Marxhausen H; To W; Sedgwick J; Ruzicka T; Lehmann P; Zlotnik A
Nat Med; 2002 Feb; 8(2):157-65. PubMed ID: 11821900
[TBL] [Abstract][Full Text] [Related]
7. Chemokine expression in diverse nonimmediate drug hypersensitivity reactions: focus on thymus activation-regulated chemokine, cutaneous T-cell-attracting chemokine, and interleukin-10.
Wang F; He D; Tang X; Zhang X
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):204-8. PubMed ID: 24932689
[TBL] [Abstract][Full Text] [Related]
8. CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.
Morel E; Escamochero S; Cabañas R; Díaz R; Fiandor A; Bellón T
J Allergy Clin Immunol; 2010 Mar; 125(3):703-10, 710.e1-710.e8. PubMed ID: 20132973
[TBL] [Abstract][Full Text] [Related]
9. TARC augments TNF-alpha-induced CTACK production in keratinocytes.
Vestergaard C; Johansen C; Christensen U; Just H; Hohwy T; Deleuran M
Exp Dermatol; 2004 Sep; 13(9):551-7. PubMed ID: 15335355
[TBL] [Abstract][Full Text] [Related]
10. CCR4 and CCR10 are expressed on epidermal keratinocytes and are involved in cutaneous immune reaction.
Fujimoto S; Uratsuji H; Saeki H; Kagami S; Tsunemi Y; Komine M; Tamaki K
Cytokine; 2008 Oct; 44(1):172-8. PubMed ID: 18782672
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB.
Vestergaard C; Johansen C; Otkjaer K; Deleuran M; Iversen L
Cytokine; 2005 Jan; 29(2):49-55. PubMed ID: 15598438
[TBL] [Abstract][Full Text] [Related]
12. Increased cutaneous T-cell-attracting chemokine levels in sera from patients with systemic sclerosis.
Hayakawa I; Hasegawa M; Matsushita T; Yanaba K; Kodera M; Komura K; Takehara K; Sato S
Rheumatology (Oxford); 2005 Jul; 44(7):873-8. PubMed ID: 15797972
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
Caproni M; Torchia D; Schincaglia E; Volpi W; Frezzolini A; Schena D; Marzano A; Quaglino P; De Simone C; Parodi A; Barletta E; Fabbri P
Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
[TBL] [Abstract][Full Text] [Related]
14. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
15. CTACK /CCL27 expression in psoriatic skin and its modification after administration of etanercept.
Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Stramazzotti D; Morichetti D; Bernardini ML; Mannello B; Fabris G; Offidani A
Br J Dermatol; 2007 Dec; 157(6):1155-60. PubMed ID: 17916208
[TBL] [Abstract][Full Text] [Related]
16. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
Tapia B; Morel E; Martín-Díaz MA; Díaz R; Alves-Ferreira J; Rubio P; Padial A; Bellón T
Clin Exp Allergy; 2007 May; 37(5):704-13. PubMed ID: 17456218
[TBL] [Abstract][Full Text] [Related]
18. CCL27 is downregulated by interferon gamma via epidermal growth factor receptor in normal human epidermal keratinocytes.
Karakawa M; Komine M; Hanakawa Y; Tsuda H; Sayama K; Tamaki K; Ohtsuki M
J Cell Physiol; 2014 Dec; 229(12):1935-45. PubMed ID: 24710735
[TBL] [Abstract][Full Text] [Related]
19. Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases.
Bellón T; Alvarez L; Mayorga C; Morel E; Torres MJ; Martín-Díaz MA; Díaz R; Radial A; Carballo M; Blanca M
Br J Dermatol; 2010 May; 162(5):1014-22. PubMed ID: 20030638
[TBL] [Abstract][Full Text] [Related]
20. Potential role of CCL27 and CCR10 expression in melanoma progression and immune escape.
Simonetti O; Goteri G; Lucarini G; Filosa A; Pieramici T; Rubini C; Biagini G; Offidani A
Eur J Cancer; 2006 May; 42(8):1181-7. PubMed ID: 16644201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
